The New Value AG is a Swiss investment and consulting company that has been active in the technology and innovation industry for over 15 years. The company invests in start-ups and growth companies in the areas of digitalization, IoT, artificial intelligence, software, and medtech. These investments are usually done in collaboration with other investors and venture capital firms.
In addition to the investment business, New Value AG also offers consulting services. The company particularly supports the start-ups it has invested in with the development and implementation of business models, marketing and sales strategies, as well as financing and investment decisions. The consultancy is based on experience, networks, and financial resources.
One of the most well-known investment divisions of New Value AG is digital business. The company invests in start-ups that develop innovative digital technologies enabling new business models or improving existing ones. Some examples of investments in this area are Beekeeper, a communication platform for employees, and Swisscom Ventures, a VC fund of Swiss telecommunications company Swisscom.
Another investment division is medtech, where New Value AG invests in companies that have developed innovative technologies for the healthcare sector. One of the largest investments of New Value AG is Sophiris Bio, which specializes in the development of medications for the treatment of prostate cancer.
In addition to these two investment divisions, New Value AG also participates in companies in the areas of IoT, Industry 4.0, cybersecurity, and energy efficiency. The company typically invests between 0.5 and 3 million Swiss francs per investment and usually holds stakes between 5% and 25%.
Overall, New Value AG participates in about 25 companies, with its portfolio constantly changing. The company has already achieved numerous successful exits in the past, including the sale of Amazee Labs to the Tamedia Group, one of the largest media companies in Switzerland, and the sale of Adaptimmune to US biotech company Adaptimmune Therapeutics.
In addition to investments, New Value AG also offers consulting services for start-ups and investors. These consultations are based on in-depth knowledge in various areas and aim to help companies define or improve their business models.
In summary, New Value AG is a Swiss company specializing in investments and consultancy in the technology and innovation industry. The various investment divisions include digital business, medtech, IoT, Industry 4.0, cybersecurity, and energy efficiency. In addition to the investment business, New Value AG also offers consulting services for start-ups and investors.